article thumbnail

Blackstone, KKR, and EQT push back on UK carried interest tax reforms amid relocation risk

Private Equity Insights

From April 2026, carried interest will be treated as income to the extent it relates to services performed in the UK, exposing non-resident executives to British tax liabilities even after they leave the country. The effective marginal rate for high earners could reach 34.1%, up from the current 32% under capital gains treatment.

Taxes 147
article thumbnail

Don't Buy Peloton Stock on Buyout Rumors

The Motley Fool

Rumors emerged earlier this month that private equity firms are considering a buyout. While some sort of buyout looks like the most likely path for Peloton, either by private equity or a larger company looking to scoop up the brand, any deal is unlikely to save longtime shareholders from enormous losses.

Buyout 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Would a Macy's Buyout Be a Miracle on 34th Street?

The Motley Fool

Ricky Mulvey: Right now the company is in a little bit of an interesting spot especially as a asset management business, a collection of businesses because the price is trading below its book value, which is just the accounting value of its assets minus its liabilities.

Buyout 246
article thumbnail

What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?

The Motley Fool

That's nearly five times the amount of its total liabilities: $359 million. CRISPR could pay off all of its liabilities, both short and long term, and still have more than $1 billion left in short-term liquid assets. What would a buyout mean for investors? For a potential acquirer, such a strong balance sheet is attractive.

Investors 246
article thumbnail

1 Growth Stock Down 97% to Buy Right Now

The Motley Fool

Let's also not forget that earlier this month Needham suggested streaming technology outfit Roku is a buyout candidate by a company on the hunt for an established brand name in the connected TV space with a base of 85.5 The company's total liabilities are just a little more than that amount, with practically none of that being long-term debt.

Buyout 228
article thumbnail

3 Growth Stocks to Buy That Could Be Massive Long-Term Winners

The Motley Fool

billion in current liabilities and no long-term debt. The company is also profitable and has a clean balance sheet, which makes me believe Progyny could be an acquisition target of some of the massive companies in the health insurance industry, though it doesn't make sense to buy a company based on hopes of a buyout.

Bidding 237
article thumbnail

Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings

The Motley Fool

This buyout brought blockbuster drug Botox into the fold, as well as major depressive disorder treatment Vraylar. Arguably the biggest headwind for J&J is the uncertain financial liability it may face from litigation tied to its now-discontinued talcum-based baby powder. Although the company proposed an $8.9

Investing 246